Outline
The present invention relates to some intestinal / enteric solvents (resistant to gastric juice acids and soluble in the duodenum)medicinal products in the form of capsules or injection, effective in the prevention or treatment of viral diseases caused by certain bacterial strains (nosocomial infections), virus strains (herpes-, influenza-, coronaviruses and ebolavirus, HIV, rotavirus, hepatitis B / C / D, Epstein-Barr virus, applicable via direct (via the digestive system / enterohepatic cycle) and indirect (circulatory and immune systems) treatment, involving the management of the physiological processes of the body, and of bile deficiency conditions and digestive-bile problems.